New drug duo aims to fight tough stomach cancers
NCT ID NCT06085755
Summary
This study is testing whether combining two existing cancer drugs works better than current treatments for advanced stomach cancer that has a low level of a protein called HER2. The trial will enroll about 61 adults whose cancer has worsened after one or two prior treatments. Researchers will first find the safest dose of the combination and then see how well it controls the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STOMACH NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.